BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8828957)

  • 1. High-dose intravenous therapy with 7S immunoglobulins in autoimmune endocrine ophthalmopathy.
    Seppel T; Schlaghecke R; Becker A; Engelbrecht V; Feldkamp J; Kornely E
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S109-14. PubMed ID: 8828957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy.
    Antonelli A; Saracino A; Alberti B; Canapicchi R; Cartei F; Lepri A; Laddaga M; Baschieri L
    Acta Endocrinol (Copenh); 1992 Jan; 126(1):13-23. PubMed ID: 1736548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with immunoglobulins in thyroid autoimmunity.
    Lecomte P; Labussière AS; Nduwayo L; Osorio-Salazar C; Lasfargues G; Diot E; Guilmot JL
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S103-7. PubMed ID: 8828956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
    Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
    Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-eye muscle antibodies and hypothyroid Graves' disease: a case report.
    Hiromatsu Y; Sato M; Tanaka K; Nonaka K; Kojima K; Sato K; Kurose S; Hoshino T; Nakashima A
    Endocrinol Jpn; 1992 Dec; 39(6):593-600. PubMed ID: 1363467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.
    Villadolid MC; Yokoyama N; Izumi M; Nishikawa T; Kimura H; Ashizawa K; Kiriyama T; Uetani M; Nagataki S
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy.
    Baschieri L; Antonelli A; Nardi S; Alberti B; Lepri A; Canapicchi R; Fallahi P
    Thyroid; 1997 Aug; 7(4):579-85. PubMed ID: 9292946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Wien Klin Wochenschr; 1992; 104(24):744-7. PubMed ID: 1363165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretibial myxedema and high-dose intravenous immunoglobulin treatment.
    Antonelli A; Navarranne A; Palla R; Alberti B; Saracino A; Mestre C; Roger P; Agostini S; Baschieri L
    Thyroid; 1994; 4(4):399-408. PubMed ID: 7711502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous immunoglobulins treatment of patients with Graves' ophthalmopathy].
    Leibe A; Levy Y; Shoenfeld Y
    Harefuah; 2001 May; 140(5):392-4, 455, 454. PubMed ID: 11419058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
    Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
    J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential diagnostic problems in unilateral euthyroid Graves' ophthalmopathy.
    Perrild H; Feldt-Rasmussen U; Bech K; Ahlgren P; Hansen JM
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):471-6. PubMed ID: 6548073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Titers of antibodies against thyroid membrane antigens in patients with Graves-Basedow disease and progressive infiltrative ophthalmopathy during treatment with glucocorticoids and retro-orbital tissue irradiation].
    Pilarska K; Syrenicz A; Czekalski S; Gołebiowska I; Andrzejewska W; Krzystolik Z
    Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):824-6. PubMed ID: 1669170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.